Salem Erode Investments Ltd (540181)
🎯 Key Takeaways
- Salem Erode Investments Ltd appears to be in a developmental or restructuring phase, with financial metrics indicating significant losses and negative returns. The company operates in the financial services sector but shows no signs of profitability, as reflected in negative ROE and ROCE.
- Revenue grew 25.4% QoQ to ₹1 in Q1FY27.
- ⚠️ Persistent operating losses and negative margins across all recent quarters indicate a deteriorating core business model.
📖 The Story
Salem Erode Investments Ltd appears to be in a developmental or restructuring phase, with financial metrics indicating significant losses and negative returns. The company operates in the financial services sector but shows no signs of profitability, as reflected in negative ROE and ROCE. Management is actively pursuing capital-raising through a proposed rights issue, suggesting an intent to fund growth or operational restructuring. The business may be in an early or turnaround stage, but current financial performance raises concerns about sustainability.
📰 What's Happening
In August 2026, the board approved a rights issue of up to 1,14,65,520 equity shares at ₹20 per share (₹19 premium), aiming to raise up to ₹2,293.10 Lakhs, with a tentative closing date of September 25, 2026, and allotment on September 28, 2026. The record date was set for September 3, 2026, enabling eligible shareholders to apply for new shares and receive rights entitlements in demat accounts via ISIN INE894E20010. This move is intended to secure regulatory approvals and facilitate capital infusion, likely to support expansion or balance sheet strengthening. The rights issue will dilute existing shareholders but signals management's proactive approach to raise funds amid limited internal cash generation.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 |
| Operating Profit | -1 | -1 | -1 | -1 | -1 |
| OPM % | -91.7% | -140.4% | -157.3% | -208.4% | -143.8% |
| Net Profit | -1 | -1 | -1 | -1 | -1 |
| EPS | ₹-0.86 | ₹-1.05 | ₹-1.10 | ₹-1.22 | ₹-1.14 |
The company has consistently reported minimal revenue (₹1 per quarter) over the past eight quarters, with operating losses widening in recent periods — OPM has deteriorated from -91.7% in June 2025 to -208.4% in March 2026. Net profit and EPS remain negative across all quarters, indicating no path to profitability yet. Despite the stable top-line of ₹1, the sharp decline in margins suggests rising cost pressures or structural inefficiencies. These trends highlight operational challenges that may be driving the need for external capital through the proposed rights issue.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance on profitability or revenue growth in the available filings. However, the board's approval of a rights issue indicates a strategic focus on capital mobilization to support future initiatives. The tentative timeline for the rights issue — with record date in September 2026 and closing by month-end — reflects a structured, time-bound effort to raise funds. No commentary on post-issue utilization of proceeds or profitability targets was found in the disclosed materials.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2018 |
|---|---|
| Equity Capital | 1 |
| Reserves | 16 |
| Borrowings | 0 |
| Total Liabilities | 18 |
| Fixed Assets | 0 |
| Investments | 8 |
| Total Assets | 18 |
The balance sheet as of March 2018 shows a minimal equity base of ₹1 with ₹16 in reserves and no borrowings, suggesting a historically low-capital structure. However, the current financial trajectory, marked by persistent losses and no operating cash flow generation, raises questions about the adequacy of this capital base. The company relies on financing activities to meet funding needs, but recent cash flow data from March 2018 shows a neutral net position, implying limited reinvestment or debt servicing capacity. The proposed rights issue appears to be a necessary step to scale operations or address structural funding gaps.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2018 |
|---|---|
| Operating | +1 |
| Investing | -1 |
| Financing | -0 |
| Net Cash Flow | -0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 75.0% | 75.0% | 75.0% | 75.0% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.7% | 0.7% | 0.7% | 0.7% |
| Public | 14.5% | 14.5% | 14.4% | 14.4% |
| # Shareholders | 1,810 | 1,831 | 1,828 | 1,851 |
Promoter holding remains stable at 75% over the past year, indicating no dilution or exit by promoters. Institutional ownership is negligible, with FII at 0% and DII at 0.73% consistently across quarters, suggesting limited market interest or analyst coverage. Public shareholding has slightly increased from 14.4% to 14.47%, reflecting minor retail investor engagement. No significant changes in shareholder composition are evident, and no pledging or selling signals have emerged from the data.
⚖️ Peer Comparison — Finance
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| BAJFINANCE | 6.63 L Cr | 32.6 | 10.4% | 18.1% | 3.82 |
| BAJAJFINSV | 3.23 L Cr | 31.7 | 11.4% | 26.5% | 5.50 |
| SHRIRAMFIN | 2.57 L Cr | 19.3 | 11.5% | 17.1% | 3.80 |
| CHOLAFIN | 1.59 L Cr | 27.6 | 9.3% | 18.9% | 6.93 |
| JIOFIN | 1.58 L Cr | 74.2 | 2.3% | 1.6% | 0.17 |
| TATACAP | 1.56 L Cr | 28.5 | 8.4% | 12.3% | 5.28 |
| ICICIAMC | 1.52 L Cr | 30.4 | 111.5% | 83.6% | 0.00 |
| BAJAJHLDNG | 1.27 L Cr | 14.3 | 12.4% | 12.3% | 0.00 |
| MUTHOOTFIN | 1.20 L Cr | 10.6 | 14.4% | 29.3% | 3.88 |
| SBIFUNDS | 1.18 L Cr | — | — | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Persistent operating losses and negative margins across all recent quarters indicate a deteriorating core business model. 2. The company's reliance on a rights issue to raise capital suggests limited access to alternative funding and potential liquidity constraints. 3. Minimal revenue and stagnant financial performance over multiple years raise concerns about business viability. 4. Lack of institutional or analyst coverage may lead to low liquidity and heightened volatility post-issue.
📋 Recent Filings
-
🟡 Board Meeting 29 August 2026The board approved a rights issue of up to 1,14,65,520 equity shares at ₹20 per share (₹19 premium), raising up to ₹2,293.10 Lakhs, with a record date...
-
🔴 Corporate Action 29 August 2026Salem Erode Investments Ltd announced September 3, 2026 as the record date for its proposed rights issue, fixing eligibility for shareholders to apply...
🧠 Analyst's Read
Salem Erode Investments Ltd is navigating a critical phase marked by financial distress and capital-raising necessity. Investors should monitor the successful completion of the rights issue and the company's ability to deploy funds into revenue-generating or margin-improving initiatives. The path to profitability and margin recovery will be key determinants of future performance, with execution risk remaining high.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd